---
title: BioIVT Blog
description: Learn valuable insights from the world of biotechnology and pharmaceutical research.
---

*Questions? We’re here to help:*

[+1 516-483-1196](tel:+1%20516-483-1196) or [+44 1444 707333](tel:+44%201444%20707333)

[Contact Us](https://www.bioivt.com/about/contact-us)

[![BioIVT-Logo-Tag-New](https://blog.bioivt.com/hubfs/BioIVT-Logo-Tag-New.png)](https://bioivt.com)

- [BioIVT.com](https://bioivt.com/)

Search

[View My Quote](https://www.bioivt.com/?showQuoteOverlay=true)

- [Home](https://bioivt.com/)
- BioIVT Blog

## [What Are Chimeric Antigen Receptor T Cell Therapies?](https://blog.bioivt.com/what-are-chimeric-antigen-receptor-t-cell-therapies)

## [What Are Controls and Why Do We Need Them?](https://blog.bioivt.com/control-matrices)

## [Fresh Versus Cryopreserved Leukopaks](https://blog.bioivt.com/fresh-vs-cryo-leukopaks)

## [What is Human AB Serum?](https://blog.bioivt.com/what-is-human-ab-serum)

## [Fresh vs Old Blood: Why Access to Fresh Blood & Blood-Derived Products is Critical to Your Research](https://blog.bioivt.com/fresh-blood-research)

## [How Monkeys, Mice, Llamas and Cows are Joining the Fight Against COVID-19](https://blog.bioivt.com/animal-models-covid19)

## [The Use of Kupffer Cells in Hepatic In Vitro Disease and Tox Models to Predict Inflammatory Response](https://blog.bioivt.com/kupffer-cells-in-hepatic-disease)

## [Coronavirus: Specimen Collection and Handling Recommendations](https://blog.bioivt.com/covid-19-specimens)

## [Use of In Vitro Systems for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis Studies](https://blog.bioivt.com/in-vitro-systems-nash-nafld)

## [Why Bank a “Quad Set”: How To Ensure Success With A Relevant Case Biospecimen Collection](https://blog.bioivt.com/high-quality-quad-sets)

## [What is Leukapheresis?](https://blog.bioivt.com/what-is-leukapheresis)

## [Understanding Regulatory Guidelines for Sourcing Human Biospecimens](https://blog.bioivt.com/understanding-regulatory-guidelines-for-sourcing-human-biospecimens)

## [Replace, Refine, Reduce:  The Humane Use of Animals in Research](https://blog.bioivt.com/replace-refine-reduce-the-humane-use-of-animals-in-research)

## [The Tightrope Walker and the Fortune Teller: Key Players in Lead Optimization](https://blog.bioivt.com/the-tightrope-walker-and-the-fortune-teller-key-players-in-lead-optimization)

## [Ancient Medicine: How Will it Affect the Future?](https://blog.bioivt.com/ancient-medicine-how-will-it-affect-the-future)

## [How Do You Silence A Gene Using siRNA In HEPATOPAC® Co-Cultures?](https://blog.bioivt.com/silence-a-gene-using-sirna-hepatopac)

## [Three Species, Endless Possibilities](https://blog.bioivt.com/three-species-endless-possibilities)

## [2019 SOT 58th Annual Meeting and Tox Expo Wrap Up](https://blog.bioivt.com/2019-sot-wrap-up)

## [Are You Using the Correct Cells in Your Research? Different Types of Cells and Their Research Applications](https://blog.bioivt.com/cell-types-research-app)

## [Why You Need Your Tissue Specimens Board-certified Pathologist Reviewed](https://blog.bioivt.com/why-you-need-your-tissue-specimens-board-certified-pathologist-reviewed)

## [Hepatitis B Virus: Looking for a Cure](https://blog.bioivt.com/hepatitis-b-virus-looking-for-a-cure)

## [What is HLA Typing And Why You Should Have Your Cells Genotyped?](https://blog.bioivt.com/what-is-hla-typing-cells-genotyped)

## [Quintuple Model Elucidates Complex Transporter-Mediated Creatinine Renal Elimination](https://blog.bioivt.com/quintuple-model-complex-transporter-mediated-creatinine-renal-elimination)

## [DTCs: Straight from the Source](https://blog.bioivt.com/dtcs-straight-from-the-source)

## [The Rise in Respiratory Research: Increases in Disease and Illness Worldwide](https://blog.bioivt.com/the-rise-in-respiratory-research-increases-in-respiratory-diseases-and-illnesses-is-causing-a-rise-in-respiratory-research)

## [Key Points in Custom Fresh Tissue Collection](https://blog.bioivt.com/key-points-in-custom-fresh-tissue-collection)

## [Hepatopac Model: The Truth Revealed](https://blog.bioivt.com/hepatopac-model-the-truth-revealed)

## [The Microbiome: Collection Matters](https://blog.bioivt.com/the-microbiome-collection-matters)

## [How Tissue Fixation Affects Your Downstream Analysis](https://blog.bioivt.com/how-tissue-fixation-affects-your-downstream-analysis)

## [North American ISSX Meeting Wrap Up](https://blog.bioivt.com/north-american-issx-meeting-wrap)

## [Cell-based Assays: A Crucial Component of the Drug Discovery Process](https://blog.bioivt.com/cell-based-assays-crucial-component-drug-discovery-process)

## [What Really is a Buffy Coat?](https://blog.bioivt.com/really-buffy-coat)

## [AACR 2018 – Hot Topics](https://blog.bioivt.com/aacr-2018-hot-topics)

## [Tissue Cross Reactivity Studies for IND/CTA Submission : Tips & Issues To Consider](https://blog.bioivt.com/tissue-cross-reactivity-studies-ind-cta-submission-tips-issues-consider)

## [Human Primary Keratinocytes in Drug Metabolism Studies](https://blog.bioivt.com/human-primary-keratinocytes-drug-metabolism-studies)

## [For the Rapid Route to Quantitative Gene Expression Data, Take the XPRESSWAY™](https://blog.bioivt.com/rapid-route-quantitative-gene-expression-data-take-xpressway)

## [Biomarkers in Urine](https://blog.bioivt.com/biomarkers-in-urine)

## [SOT 2018 Poster Session Wrap Up](https://blog.bioivt.com/sot-2018-poster-session-wrap)

## [The New FDA Draft Guidance on In Vitro DDI Studies: How Will It Impact You?](https://blog.bioivt.com/new-fda-draft-guidance-vitro-ddi-studies-will-impact)

## [Top Tips for Hepatocyte Handling](https://blog.bioivt.com/top-tips-hepatocyte-handling)

## [Respiratory Disease Modeling and the Use of Primary Cells](https://blog.bioivt.com/respiratory-disease-modeling-and-the-use-of-primary-cells)

## [Streamlining Immune Cell Activation Analysis in Animal and Human Samples](https://blog.bioivt.com/streamlining-immune-cell-activation-analysis-animal-human-samples)

## [Has Major Cancer Gene Met Its Match?](https://blog.bioivt.com/major-cancer-gene-met-match)

## [CTE & ALS at the Forefront at the Powering Precision Health Summit](https://blog.bioivt.com/cte-als-forefront-powering-precision-health-summit)

## [September is Blood Cancer Awareness Month!](https://blog.bioivt.com/september-blood-cancer-awareness-month)

## [Top Anticoagulants: Mechanisms & Usage Recommendations](https://blog.bioivt.com/top-anticoagulants-mechanisms-usage-recommendations)

## [Skin-derived Primary Cells and Their Uses for Cosmetic Research](https://blog.bioivt.com/skin-derived-primary-cells-uses-cosmetic-research)

## [How Blocking DNA-Repairing Mechanisms Could Combat Glioblastomas](https://blog.bioivt.com/blocking-dna-repairing-mechanisms-combat-glioblastomas)

## [A Predictive Model for Drug Response?](https://blog.bioivt.com/predictive-model-drug-response)

## [The Telomere: Does Length Impact Cancer Related Genomic Alterations?](https://blog.bioivt.com/telomere-length-impact-cancer-related-genomic-alterations)

## [Using Immunotherapy and Cell Alteration to Combat Lung Cancer](https://blog.bioivt.com/using-immunotherapy-cell-alteration-combat-lung-cancer)

## [Hiding in Plain Sight: New Human Organ Classification](https://blog.bioivt.com/hiding-plain-sight-new-human-organ-classification)

## [Research and Discovery Process in Drug Development](https://blog.bioivt.com/research-discovery-process-drug-development)

## [Gene Expression and Tissue Variety Uncovers Disease Subtypes in Crohn’s Disease](https://blog.bioivt.com/gene-expression-tissue-variety-uncovers-disease-subtypes-crohns-disease)

## [FFPE or Flash Frozen? Working with Human Biospecimens In Research](https://blog.bioivt.com/ffpe-flash-frozen-working-human-biospecimens-research)

## [MicroRNA Analysis in KRAS-Driven Tumor Growth](https://blog.bioivt.com/microrna-analysis-kras-driven-tumor-growth)

## [Tissue Vulnerability and Protein Characterization in Alzheimer’s Disease](https://blog.bioivt.com/tissue-vulnerability-protein-characterization-alzheimers-disease)

## [Tissue Variety in Breast Cancer Research](https://blog.bioivt.com/tissue-variety-breast-cancer-research)

## [Mutation Analysis in Cancer Research](https://blog.bioivt.com/mutation-analysis-cancer-research)

## [Leveraging Human Tissue for Cell Type Conversation](https://blog.bioivt.com/leveraging-human-tissue-cell-type-conversation)

### Register for our newsletter

### Search the blog

Search

### Recent articles

### Tags

- [Uncategorized (30)](https://blog.bioivt.com/tag/uncategorized)
- [Precision Medicine (15)](https://blog.bioivt.com/tag/precision-medicine)
- [Genomics & Proteomics (11)](https://blog.bioivt.com/tag/genomics-proteomics)
- [Disease State Tissues (9)](https://blog.bioivt.com/tag/disease-state-tissues)
- [Oncology (7)](https://blog.bioivt.com/tag/oncology)

### Sign up for our newsletter

We’ll send you periodic updates about new products and services

### Questions?

You can reach us by phone, email or

[click here to contact us.](https://www.bioivt.com/about/contact-us/)

### North America, Asia Pacific

### Middle East & Africa

[516-483-1196](tel:516-483-1196) [customerservice@bioivt.com](mailto:customerservice@bioivt.com)

### Europe

[+ 44 1444 707333](tel:+%2044%201444%20707333) [cseurope@bioivt.com](mailto:cseurope@bioivt.com)

© 2024 BioIVT. BIOIVT & ELEVATING SCIENCE are registered trademarks of BioIVT LLC.

- [Trademarks](https://www.bioivt.com/trademarks)
- [Privacy Policy](https://www.bioivt.com/privacy-policy)
- [Terms and Conditions](https://www.bioivt.com/terms-and-conditions)